MAM
RETA

Martingale Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Martingale Asset Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,202
Closed -$346K – 1006
2017
Q4 		$346K Sell
12,202
-2,899
-19% -$82.2K ﹤0.01% 874
2017
Q3 		$470K Buy
+15,101
New +$470K 0.01% 850